• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back

Phenytoin (diphenylhydatoin)

Prodrug:fosphenytoin which contains no prophylene glycol(decr. BP),it is water soluble and also used for epilepticus


MOA: use dependent Na+ channel inhibition as a result of state selective binding


Good oral absorption--depends on formulation---iv injection is also possible .


Pharmacokinetics:significant plasma protein binding,aspirin & sulfonamides may cause displacement.


Metabolism:saturable metabolism by CYP2C9,CYP2C19 & it is dose dependent. Its level increases at a steady state.T1/2:6-24h---5days. It is a strong enzyme inducer,so it decreases other drugs efficacy.


Also used for arrythmias


SE: headache,dizziness,but no sedation, teratogenic.

Carbamazepine

Chemically related to TCAs.


MOA: use dependent Na+ channel inhib


Metabolism:metabolized in the liverby CYP3A4,CYP2C9 with an active metabolite+ enterohepatic circulation. T1/2:36hrs. It is a strong enzyme inducer,more effective in psychomotor epilepsy. Also used for ethanol withdrawal & manic depression.


SE: dizziness,double vision,sedation, water retention--dilutional hyponatremia. teratogenic(spinal bifida)

Phenobarbital

Long acting barbiturate.


MOA: +ve allosteric modulator of GABA a rec. It increases neuronal excitation. Has good oral absorption.


Metabolism:T 1/2 100h. 75% in the liver25% unchanged in the urine. It is astrong enzyme inducer(CYP sys.). Given i.v for status epilepticus.


SE: sedation,respiratory depression, teratogenic.

Primidone

2-deoxy-phenobarbitol--partially metabolised into phenobarbital.


MOA: Na+ channel blocker


Orally used

newer antiepileptics

oxcarbazepine


eslicarbazepine acetate


vigabatrin


tiagabine


gabapentin

Oxcarbazepine

Keto analog of carbamazepine


MAO: active metabolite mediates its action---S licarbazepine inhibits Na+ channel. Mainly for partial seizures.


SE: more water retention but less enzyme induction than carbamazapine

eslicarbazepine acetate

Prodrug of S-licarbazepine


MOA:oral use--converted to S licarbazepine during first pass metabolism.


SE:dizziness,headache,double vision,sedation.


Used for partial seizures(once a day)

Vigabatrin

MOA:irriversible inhibition of GABA transaminase--incr. GABA level--neuronal inhibition


Used for partial seizure


Metabolism:unchanged by the kidney


SE:sedation,depression,visual disturbance

Tiagabine

MOA: inhibits GABA reuptake--incr. GABA level--neuronal inhib.


Used for partial seizure


Metabolism: by CYP3A4


SE:sedation,dizziness, confusion

Gabapentin

MOA:analog of GABA but does not act on GABA rec. Inhibits presynaptic Ca2+ channels--reduce neurotransmitter release


Metabolism: unchanged by the kidne


Others: for neuropathic pain and acute mania


SE: sedation,ataxia,tremor,weight gain